Skip to content

Vericel

US · VCEL #2759 by market cap Listed 1970
57.52 -0.74 -1.27%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions increased by 3 in the most recent period (2026/Q3).
  • Total institutional ownership fell 1.5 percentage points.

Ownership vs. money flow

Aligned

Institutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
109.60% -1.47pp
Institutions
389 +3
As of
2026/Q3 vs. prior period

Holder types

Mutual Fund90.70%
Hedge Fund10.12%
Public Company4.54%
Government Pension Fund1.71%
Insurance Company1.33%
Individual/Insider1.20%
Private Company0.82%
Sovereign Wealth Fund0.19%
Family Office/Trust0.13%

Top holders as of 2026-09-30

BlackRock 16.00% · 8.17M sh
State Street Global Advisors 6.28% · 3.20M sh
Congress Asset Management Company, LLP 5.00% · 2.55M sh
Vanguard Capital Management, LLC 4.43% · 2.26M sh
William Blair Investment Management, LLC 3.84% · 1.96M sh
BNPP Asset Management Holding 3.21% · 1.64M sh
Conestoga Capital Advisors, LLC 3.08% · 1.57M sh
GW&K Investment Management, LLC 3.01% · 1.54M sh
Soleus Capital Management, L.P. 2.86% · 1.46M sh
Geode Capital Management, LLC 2.74% · 1.40M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 19 buys · 31 sells

NameRoleStake
Dominick Colangelo Chief Executive Officer 0.61%
Jonathan Hopper Chief Medical Officer 0.15%
Alan Rubino Independent Director 0.13%
Heidi Hagen Independent Director 0.07%
Robert Zerbe Independent Chairperson 0.06%
Paul Wotton Independent Director 0.04%
Kevin McLaughlin Independent Director 0.04%
Michael Halpin Chief Operating Officer 0.03%
Joseph Mara Chief Financial Officer 0.03%
Lisa Wright Independent Director 0.03%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-11-12 Jonathan Siegal Principal Accounting Officer, VP & Corporate Controller Intent to Sell (Form 144) -1,885 $57.71
2026-11-10 Joseph Mara Chief Financial Officer Derivative Exercise and Sale -25,008 $43.63–59.75
2026-11-10 Joseph Mara Chief Financial Officer Other Derivative Acquisition +25,008 $43.63
2026-11-10 Joseph Mara Chief Financial Officer Intent to Sell (Form 144) -8 $59.75
2026-11-09 Kevin McLaughlin Independent Director Derivative Exercise and Sale -7,000 $13.05–58.96
2026-11-09 Kevin McLaughlin Independent Director Other Derivative Acquisition +7,000 $13.05
2026-11-08 Robert Zerbe Independent Chairperson Derivative Exercise and Sale -2,000 $13.05–57.88
2026-11-08 Robert Zerbe Independent Chairperson Other Derivative Acquisition +2,000 $13.05
2026-11-08 Joseph Mara Chief Financial Officer Intent to Sell (Form 144) -25,000 $58.26
2026-11-05 Joseph Mara Chief Financial Officer Other Derivative Acquisition +50,000 $29.82–34.90
2026-11-05 Joseph Mara Chief Financial Officer Intent to Sell (Form 144) -28,641 $53.42
2026-11-05 Joseph Mara Chief Financial Officer Derivative Exercise and Sale -28,641 $29.82–53.43
2026-11-04 Robert Zerbe Independent Chairperson Derivative Exercise and Sale -5,500 $13.05–55.00
2026-11-04 Robert Zerbe Independent Chairperson Intent to Sell (Form 144) -3,000 $52.23
2026-11-04 Sean Flynn Chief Legal Officer Derivative Exercise and Sale -15,000 $16.25–51.92
2026-11-04 Joseph Mara Chief Financial Officer Other Acquisition +21,359 $29.82–34.90
2026-11-04 Joseph Mara Chief Financial Officer Open Market Disposition -21,359 $53.40–53.73
2026-11-04 Jonathan Siegal Principal Accounting Officer, VP & Corporate Controller Derivative Exercise and Sale -1,500 $34.90–52.90
2026-11-03 Robert Zerbe Independent Chairperson Intent to Sell (Form 144) -2,500 $45.40
2026-08-11 Kevin McLaughlin Independent Director Derivative Exercise and Sale -7,000 $13.05–44.53

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Vericel discussion 0 comments

Add a comment